The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...

The committee noted that the clinical evidence showed Optilume to be effective in improving clinically relevant outcomes including anatomical success, peak flow rate and international prostate symptom ...

PORTSMOUTH, N.H., July 10, 2025 /PRNewswire/ -- Effective July 1, 2025, Blue Cross Blue Shield of Michigan (BCBSM) has issued a new medical policy under CPT code 52284, extending coverage for Laborie ...

PORTSMOUTH, N.H., Jan. 17, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its ...

Urotronic's Drug Coated Balloon Provides Minimally-Invasive, Durable Alternative for Stricture Patients in Europe MINNEAPOLIS, Sept. 23, 2020 /PRNewswire/ -- Urotronic, Inc., a Minnesota-based medical ...

- Optilume® is an effective alternative to traditional endoscopic stricture treatments for male anterior urethral strictures, offering minimally invasive, immediate relief. Optilume's ...

MINNEAPOLIS, Dec. 13, 2021 /PRNewswire/ -- Urotronic, Inc., a Minnesota based medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Optilume® ...

NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...

MINNEAPOLIS, Sept. 23, 2020 /PRNewswire/ -- Urotronic, Inc., a Minnesota-based medical device company announced today it has received Conformité Européene (CE) Mark approval for its innovative ...

Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its Optilume® Drug-Coated Balloon (DCB). The ...

MINNEAPOLIS, Sept. 23, 2020 /PRNewswire/ -- Urotronic, Inc., a Minnesota-based medical device company announced today it has received Conformité Européene (CE) Mark approval for its innovative ...